Vitamin D and its receptor polymorphisms are associated with glaucoma
J Fr Ophtalmol . 2020 Sep 28;S0181-5512(20)30400-9. doi: 10.1016/j.jfo.2020.02.016.
Z S Ulhaq 1
Note: Problems with the Vitamin D Receptor are not notice by vitamin D blood tests
The risk of 44 diseases at least double with poor Vitamin D Receptor as of Oct 2019
Items in both categories Vision and Vitamin D Receptor are listed here:
- Resveratrol, which increased Vitamin D in the cell, improves vision – July 2022
- An ocular disease can be associated with low vitamin D and 1 of 5 poor vitamin D genes – June 2022
- Poor vision associated with poor Vitamin D or poor Vit. D genes – June 2022
- Glaucoma 3.1 X more likely if a poor Vitamin D Receptor – Sept 2020
- Vitamin D and Myopia, AMD, Diabetic Retinopathy, Uveitis, Glaucoma, VDR etc. – May 2015
- Diabetic Retinopathy 2 X more likely if poor Vitamin D Receptor – meta-analysis Nov 2016
- Myopia 2 times more likely if Vitamin D Receptor problem – June 2011
Vitamin D Receptor activation can be increased by any of: Resveratrol, Omega-3, Magnesium, Zinc, Quercetin, non-daily Vit D, Curcumin, intense exercise, Ginger, Essential oils, etc Note: The founder of VitaminDWiki uses 10 of the 12 known VDR activators
7+ VitaminDWiki pages with GLAUCOMA in title
This list is automatically updated
Purpose: To clarify the association between serum vitamin D levels and its receptor polymorphisms with glaucoma risk.
Methods: A meta-analysis was performed from available studies investigating serum vitamin D levels and vitamin D receptor (VDR) polymorphisms in glaucoma patients and controls.
Results: Twelve studies in total, including 130,676 and 476 subjects, were analysed for the association between serum vitamin D levels and VDR polymorphisms with glaucoma, respectively. Collectively, it was found that glaucoma patients have lower levels of vitamin D compared to controls (SMD=-1.16, 95% CI=-1.56 0.76, P<0.00001). In parallel, the pooled results showed a significant association between glaucoma and allelic (b vs. B, OR=1.84, 95% CI=1.37-2.46, P=0.00001) and recessive (bb vs. Bb+BB, OR = 3.16, 95% CI=1.30-7.66, P=0.001) models of VDR BsmI (rs1544410) polymorphism, but not with VDR TaqI (rs731236) or FokI (rs2228570) polymorphisms.
Conclusion: This meta-analysis suggests that patients with glaucoma may have vitamin D deficiency. In addition, the vitamin D signalling cascade may be a contributing factor in developing glaucoma, which is supported by the evidence that b allele carriers of VDR BsmI exhibited an increase in the risk of glaucoma. Thus, dietary supplementation of vitamin D may become an important approach as an additional treatment for glaucoma.